Jennifer Regan
Acute Care · Saint Louis, MONPI 1407519960
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $3,026 and has fallen 77.7% since, to $675 in 2025. Among acute care clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $68.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$254
- E.r. Squibb & Sons, L.L.C.$212
- Kestra Medical Technology Services, Inc.$183
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$158
- Impulse Dynamics (USA) Inc.$157
- plus $686 from 16 others
What the payments were for
- Travel & lodging$2,31543%
- Food & beverage$3,06757%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $3,767 |
| Medtronic | 3 | $254 |
| E.r. Squibb & Sons, L.L.C. | 6 | $212 |
| Kestra Medical Technology Services, Inc. | 5 | $183 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $158 |
| Impulse Dynamics (USA) Inc. | 1 | $157 |
| Biosense Webster, Inc. | 1 | $122 |
| AstraZeneca | 4 | $87 |
| Novo Nordisk | 4 | $69 |
| Amgen | 4 | $59 |
| Bayer | 3 | $53 |
| Pfizer | 3 | $52 |
| Merck | 3 | $47 |
| Acera Surgical, Inc. | 1 | $27 |
| Boehringer Ingelheim | 2 | $26 |
| Novartis | 2 | $26 |
| Smith+Nephew | 1 | $24 |
| Sanofi | 1 | $21 |
| Nevro Corp. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Biotronik Inc. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$2,060
- WATCHMAN Access System$381
- OPTIMIZER$315
- COBALT DR MRI SURESCAN$142
- QDOT MICRO$122
How this compares
$5,418 in reported general payments places this provider in the 95th percentile of 272 acute care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 314 | $239,084 |
| XareltoRivaroxaban | 104 | $84,084 |
| EntrestoSacubitril/Valsartan | 55 | $46,103 |
| FarxigaDapagliflozin Propanediol | 13 | $22,048 |
| Dofetilide | 56 | $6,387 |
| Verapamil Er PmVerapamil Hcl | 13 | $2,855 |
| Metoprolol Succinate | 263 | $2,497 |
| Flecainide Acetate | 115 | $2,425 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 62 | $1,259 |
| Amiodarone Hcl | 94 | $827 |
| Torsemide | 72 | $815 |
| SotalolSotalol Hcl | 49 | $703 |
| Spironolactone | 71 | $650 |
| Potassium Chloride | 54 | $589 |
| Propafenone Hcl | 15 | $556 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $52 | $239,084314 claims |
| Johnson & JohnsonXarelto | $19 | $84,084104 claims |
| NovartisEntresto | $26 | $46,10355 claims |
| AstraZenecaFarxiga | $87 | $22,04813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 272 acute care providers in Missouri.
Other acute care in Saint Louis
- Kayla TourvilleSaint Louis$5K
- Christa SinkSaint Louis$5K
- Shalu LamaSaint Louis$3K
- Emily GavinSaint Louis$3K
- Brittany ZellerSaint Louis$3K
- Molly HulsenSaint Louis$2K
- Patricia ClarkSaint Louis$2K
- Paula VaughnSaint Louis$2K
- Jennifer BurnsSaint Louis$2K
- Kamela Casey-BaggetteSaint Louis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.